To Any Expert with knowledge of Clinical Trial Analysis | IMGN Message Board Posts

ImmunoGen, Inc.

  IMGN website

IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  49872 of 49989  at  9/20/2019 12:41:29 PM  by

sooner_or_later55


 In response to msg 49871 by  erniewerner
view thread

Re: To Any Expert with knowledge of Clinical Trial Analysis

Thank you for that information. I was wondering if a trial must be based on only ONE endpoint or could they have a trial that have both so that if the PFS did not meet their criteria, they could continue same trial to determine OS. It would allow having the chance of a faster approval but if the endpoint of PFS is not met, there would be no requirement to start another trial for OS.

When the data is released next Monday, would be interested in further comments.

Some of my recent postings have had some humor and discontent involved but actually I am still hoping for some positive news not only for the investors, but also for the patients with ovarian cancer. They need some good news!!

Sooner


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 221
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
49873 Re: To Any Expert with knowledge of Clinical Trial Analysis erniewerner 1 9/20/2019 12:59:08 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...